Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.

@article{Strandell2011ReportingPI,
  title={Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.},
  author={Johanna Strandell and Ola Caster and Andrew Bate and Niklas Nor{\'e}n and Ivor Ralph Edwards},
  journal={Drug safety},
  year={2011},
  volume={34 3},
  pages={253-66}
}
BACKGROUND Adverse drug interaction surveillance in collections of Individual Case Safety Reports (ICSRs) remains underdeveloped. Most efforts to date have focused on disproportionality analysis, but the empirical support for its value is based on isolated examples. Additionally, too little attention has been given to the potential value of the detailed content of ICSRs for improved adverse drug interaction surveillance. OBJECTIVE The aim of the study was to identify reporting patterns… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Stockley’s drug interactions alerts (xml) [including data up to 2009-10-19

  • K Baxter, editor
  • 2009
Highly Influential
6 Excerpts

VigiBase, the WHO global ICSR database system: basic facts

  • M. Lindquist
  • Drug Inf J 2008;
  • 2008
Highly Influential
10 Excerpts

Concomitant use of glucosamine potentiates the effect of warfarin

  • QY Yue, J Strandell, O. Myrberg
  • Drug Saf 2006;
  • 2006
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…